Weik Capital Management Biogen Inc. Transaction History
Weik Capital Management
- $235 Million
- Q1 2024
A detailed history of Weik Capital Management transactions in Biogen Inc. stock. As of the latest transaction made, Weik Capital Management holds 1,440 shares of BIIB stock, worth $324,936. This represents 0.13% of its overall portfolio holdings.
Number of Shares
1,440
Previous 1,260
14.29%
Holding current value
$324,936
Previous $326,000
4.91%
% of portfolio
0.13%
Previous 0.15%
Shares
3 transactions
Others Institutions Holding BIIB
# of Institutions
1,047Shares Held
126MCall Options Held
1.37MPut Options Held
1.35M-
Vanguard Group Inc Valley Forge, PA16.6MShares$3.74 Billion0.07% of portfolio
-
Primecap Management CO Pasadena, CA16.2MShares$3.66 Billion2.65% of portfolio
-
Black Rock Inc. New York, NY14.1MShares$3.19 Billion0.07% of portfolio
-
State Street Corp Boston, MA6.75MShares$1.52 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.17MShares$1.17 Billion0.68% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $32.5B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...